Addex Therapeutics Stock Buy Hold or Sell Recommendation

ADXN Stock  USD 5.55  0.16  2.80%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Addex Therapeutics is 'Sell'. Macroaxis provides Addex Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ADXN positions. The advice algorithm takes into account all of Addex Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Osisko Gold Ro's buy or sell advice are summarized below:
Real Value
Hype Value
Market Value
Naive Value
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Addex Therapeutics given historical horizon and risk tolerance towards Addex Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Addex Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Addex Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
In addition, we conduct extensive research on individual companies such as Addex and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in commodities.

Execute Addex Therapeutics Buy or Sell Advice

The Addex recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Addex Therapeutics. Macroaxis does not own or have any residual interests in Addex Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Addex Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Addex TherapeuticsBuy Addex Therapeutics

Market Performance




Hype Condition


Current Valuation


Odds of Distress


Economic Sensitivity


Analyst Consensus


Financial Strenth (F Score)


Financial Leverage


Reporting Quality (M-Score)

For the selected time horizon Addex Therapeutics has a Mean Deviation of 5.33, Standard Deviation of 6.72 and Variance of 45.11
We provide trade advice to complement the prevailing expert consensus on Addex Therapeutics. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Addex Therapeutics is not overpriced, please confirm all Addex Therapeutics fundamentals, including its debt to equity, retained earnings, and the relationship between the ebitda and earnings per share . Given that Addex Therapeutics has a price to sales of 2.71 X, we suggest you to validate Addex Therapeutics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Addex Therapeutics Trading Alerts and Improvement Suggestions

Addex Therapeutics generated a negative expected return over the last 90 days
Addex Therapeutics has high historical volatility and very poor performance
Addex Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 1.42 M. Net Loss for the year was (20.8 M) with profit before overhead, payroll, taxes, and interest of 1.44 M.
Addex Therapeutics currently holds about 8.81 M in cash with (16.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.4.
Addex Therapeutics has a frail financial position based on the latest SEC disclosures
Latest headline from Addex Reports Q3 2023 Financial Results and Provides Corporate ... -

Addex Therapeutics Returns Distribution Density

The distribution of Addex Therapeutics' historical returns is an attempt to chart the uncertainty of Addex Therapeutics' future price movements. The chart of the probability distribution of Addex Therapeutics stock daily returns describes the distribution of returns around its average expected value. We use Addex Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Addex Therapeutics returns is essential to provide solid investment advice for Addex Therapeutics.
Mean Return
Value At Risk
Potential Upside
Standard Deviation
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Addex Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Addex Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Addex Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Addex Therapeutics backward and forwards among themselves. Addex Therapeutics' institutional investor refers to the entity that pools money to purchase Addex Therapeutics' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Last TransactionTypeSharesValue
Nea Management Company Llc2023-09-30Common Shares180 K408.3 K
Armistice Capital Llc2023-09-30Common Shares537 K206.4 K
Endurant Capital Management Lp2023-03-31Common Shares120.7 K114.3 K
Old Mission Capital Llc 12023-03-31Common Shares65.7 K62.2 K
Virtu Financial Llc2023-03-31Common Shares42.9 K41 K
Citadel Advisors Llc2023-03-31Common Shares34.4 K32.5 K
Susquehanna International Group Llp2023-03-31Common Shares15.1 K14.3 K
Renaissance Technologies Llc2022-12-31Common Shares21.9 K14 K
Baader Bank Aktiengesellschaft2023-09-30Common Shares19.2 K6.6 K
Jane Street Group Llc2023-09-30Common Shares10.6 K4.1 K
Ubs Group Ag2023-09-30Common Shares74.028.0
Note, although Addex Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Addex Therapeutics Cash Flow Accounts

201820192020202120222023 (projected)
Capital Expenditure(9.1K)(28.5K)(59.4K)(31.5K)(581.0)(626.87)
Depreciation Amortization and Accretion2.9K333.8K378.8K347.6K323.1K305.3K
Net Cash Flow or Change in Cash and Cash Equivalents39.1M(10.0M)(12.2M)1.7M(13.3M)(13.7M)
Issuance Purchase of Equity Shares40.5M6.0K720.0K13.6M1.1M1.1M
Net Cash Flow from Financing37.4M(463.7K)46.4K16.4M3.1M3.2M
Net Cash Flow from Investing(56.4K)(43.3K)(59.4K)(30.3K)3.0K3.2K
Net Cash Flow from Operations1.8M(9.5M)(12.2M)(14.7M)(16.4M)(16.9M)
Effect of Exchange Rate Changes on Cash10.5K(144.3K)(648.7K)122.5K(196.2K)(211.7K)

Addex Therapeutics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Addex Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Addex Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Addex stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over NYSE Composite
Beta against NYSE Composite1.15
Overall volatility
Information ratio -0.08

Addex Therapeutics Volatility Alert

Addex Therapeutics is displaying above-average volatility over the selected time horizon. Investors should scrutinize Addex Therapeutics independently to ensure intended market timing strategies are aligned with expectations about Addex Therapeutics volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Addex Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Addex Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Addex Therapeutics Fundamentals Vs Peers

Comparing Addex Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Addex Therapeutics' direct or indirect competition across all of the common fundamentals between Addex Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Addex Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Addex Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Addex Therapeutics by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Addex Therapeutics to competition
FundamentalsAddex TherapeuticsPeer Average
Return On Equity-1.98-0.31
Return On Asset-0.77-0.14
Operating Margin(8.06) %(5.51) %
Current Valuation541.07 K16.62 B
Shares Outstanding821.98 K571.82 M
Shares Owned By Institutions49.50 %39.21 %
Number Of Shares Shorted5.55 K4.71 M
Price To Book1.26 X9.51 X
Price To Sales2.71 X11.42 X
Revenue1.42 M9.43 B
Gross Profit1.44 M27.38 B
EBITDA(20.17 M)3.9 B
Net Income(20.8 M)570.98 M
Cash And Equivalents8.81 M2.7 B
Cash Per Share1.40 X5.01 X
Total Debt373.13 K5.32 B
Debt To Equity0.049 %48.70 %
Current Ratio2.55 X2.16 X
Book Value Per Share0.08 X1.93 K
Cash Flow From Operations(16.44 M)971.22 M
Short Ratio0.64 X4.00 X
Earnings Per Share(20.52) X3.12 X
Number Of Employees2418.84 K
Market Capitalization5.59 M19.03 B
Total Asset8.28 M29.47 B
Retained Earnings(349.86 M)9.33 B
Working Capital4.55 M1.48 B
Current Asset32.02 M9.34 B
Current Liabilities4.82 M7.9 B
Z Score-57.358.72
Net Asset8.28 M

Addex Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Addex . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Addex Therapeutics Buy or Sell Advice

When is the right time to buy or sell Addex Therapeutics? Buying financial instruments such as Addex Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2020 2021 2022 2023 (projected)
Current Assets19.5M21.9M7.8M8.0M
Total Assets20.2M22.5M8.3M8.5M

Use Investing Ideas to Build Portfolios

In addition to having Addex Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Outsourcing Thematic Idea Now

Outsourcing Theme
Companies involved in providing outsourcing and staffing services to business across different domains. The Outsourcing theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Outsourcing Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:
Check out Addex Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Addex Stock analysis

When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.